Alyeska Investment Group’s NxStage Medical Inc. NXTM Stock Holding History

Alyeska Investment Group’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,045,899	Closed	-$29.9M	–	493
2018 Q4	$29.9M	Buy	1,045,899 +813,921	+351%	+$23.1M	0.44%	86
2018 Q3	$6.47M	Sell	231,978 -77,933	-25%	-$2.19M	0.07%	221
2018 Q2	$8.65M	Sell	309,911 -135,338	-30%	-$3.63M	0.08%	227
2018 Q1	$11.1M	Buy	445,249 +4,549	+1%	+$111K	0.09%	211
2017 Q4	$10.7M	Buy	440,700 +121,034	+38%	+$3.19M	0.08%	209
2017 Q3	$8.82M	Buy	+319,666	New	+$8.53M	0.07%	253

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Alyeska Investment Group's NXTM Position: Q1 2019 in Review

Alyeska Investment Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,045,899 shares — an estimated $29.9M sold.

Alyeska Investment Group first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $29.9M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Alyeska Investment Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Alyeska Investment Group sold 1,045,899 NxStage Medical Inc. shares in Q1 2019, an estimated $29.9M.
Alyeska Investment Group first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Alyeska Investment Group's NxStage Medical Inc. position peaked at $29.9M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Alyeska Investment Group's 13F filing for Q1 2019, filed 15 May 2019.